These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4300624)

  • 1. The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice.
    Piazza M; Pane G; De Ritis F
    Arch Gesamte Virusforsch; 1967; 22(3):472-4. PubMed ID: 4300624
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the times of disappearance and re-appearance in the bone marrow and lymph nodes of MHV-3 hepatitis virus after intravenous inoculation in receptive mice].
    Lista D; Visconti M; De Marco F; Piazza M
    Boll Soc Ital Biol Sper; 1969 Mar; 45(6):323-5. PubMed ID: 4321459
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of phenobarbital on MHV-3 viral hepatitis of the mouse.
    Budillon G; Carrella M; De Marco F; Mazzacca G
    Pathol Microbiol (Basel); 1973; 39(6):461-6. PubMed ID: 4356801
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential growth of MHV (PRI) and MHV (C3H) in genetically resistant C3H mice rendered susceptible by eperythrozoon infection.
    Lavelle GC; Bang FB
    Arch Gesamte Virusforsch; 1973; 41(3):175-84. PubMed ID: 4353793
    [No Abstract]   [Full Text] [Related]  

  • 5. Catalase activity of serum and hepatic tissue in experimental murine hepatitis by MHV-3 virus and in acute experimental CCl-4 poisoning.
    De Ritis F; Ruggiero G; Filosa E
    Enzymol Biol Clin (Basel); 1969; 10(2):122-30. PubMed ID: 4305704
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
    Le Prevost C; Levy-Leblond E; Virelizier JL; Dupuy JM
    J Immunol; 1975 Jan; 114(1 Pt 1):221-5. PubMed ID: 163277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the ATP content in liver tissue of the mouse in experimental virus MHV-3-hepatitis].
    Mancini A; Galanti B; Giusti G
    Enzymol Biol Clin (Basel); 1966; 6(4):279-87. PubMed ID: 4288710
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-dependent response of mice to a mouse hepatitis virus, MHV-S.
    Taguchi F; Aiuchi M; Fujiwara K
    Jpn J Exp Med; 1977 Apr; 47(2):109-15. PubMed ID: 194073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase activity of mouse serum and liver tissue in some conditions of experimental liver damage.
    Cacciatore L; Antoniello S
    Enzymologia; 1971 Aug; 41(2):112-20. PubMed ID: 4330826
    [No Abstract]   [Full Text] [Related]  

  • 10. Histochemistry of glutamic-oxaloacetic transaminase in mouse liver during MHV-3 infection.
    Paradisi F; Graziano L; Maio G
    Experientia; 1972 May; 28(5):551-2. PubMed ID: 4339276
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mouse pancreas involvement in murine hepatitis virus infection].
    Fujiwara K; Tamura T; Hirano N; Takenaka S
    C R Seances Soc Biol Fil; 1975; 169(2):477-80. PubMed ID: 171039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone in hepatitis by MHV-3 virus: study of the dynamics of virus multiplication in relation to time of prednisolone injection.
    Piazza M; Visconti M; Lista D; De Ritis F
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):43-6. PubMed ID: 4332333
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis and brain lesions due to mouse hepatitis virus accompanied by wasting in nude mice.
    Sebesteny A; Hill AC
    Lab Anim; 1974 Sep; 8(3):317-26. PubMed ID: 4371665
    [No Abstract]   [Full Text] [Related]  

  • 14. γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.
    Wu D; Yan WM; Wang HW; Huang D; Luo XP; Ning Q
    Curr Med Sci; 2018 Aug; 38(4):648-655. PubMed ID: 30128874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of hepatitis induced with MHV-3 virus in splenectomized mice].
    Piazza M; Balestrieri G; Lista D
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1749-51. PubMed ID: 4291290
    [No Abstract]   [Full Text] [Related]  

  • 17. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of GB hepatitis agent in tamarins.
    Karayiannis P; Petrovic LM; Fry M; Moore D; Enticott M; McGarvey MJ; Scheuer PJ; Thomas HC
    Hepatology; 1989 Feb; 9(2):186-92. PubMed ID: 2536347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyribonuclease I and II activities in liver and spleen of mice experimentally infected by mouse hepatitis virus.
    Giusti G; Cacciatore L; De Ritis F
    Proc Soc Exp Biol Med; 1965 Dec; 120(3):822-5. PubMed ID: 4285647
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ribonuclease activity of the liver and spleen during experimental mouse hepatitis caused by MHV-3 virus].
    Cacciatore L; Giusti G; Ruggiero G
    Boll Soc Ital Biol Sper; 1965 Jun; 41(11):612-4. PubMed ID: 4290339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.